RIDGEWOOD, NJ, February 16, 2024 – The Valley Hospital is pleased to announce treatment of the first patient in New Jersey, and one of the first in the United States, with a new, outpatient, FDA-approved approach that uses pulsed electrical fields, rather than thermal ablation, for patients with atrial fibrillation (AFib). The technology is called the PulseSelect? Pulsed Field Ablation (PFA) System and is manufactured by Medtronic.